TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Fosun International ( (HK:0656) ) has issued an announcement.
Fosun Pharma, a subsidiary of Fosun International, has entered into a Mutual Supply Framework Agreement with CQ Pharma Holdings, effective from January 1, 2026, to December 31, 2028. This agreement, which renews a previous arrangement, involves the supply and purchase of pharmaceutical products and related services between the two groups. The transactions are considered continuing connected transactions under Hong Kong Listing Rules but are exempt from certain requirements due to their ordinary business nature. This strategic collaboration is expected to streamline operations and strengthen Fosun Pharma’s industry positioning.
The most recent analyst rating on (HK:0656) stock is a Hold with a HK$4.50 price target. To see the full list of analyst forecasts on Fosun International stock, see the HK:0656 Stock Forecast page.
More about Fosun International
Fosun International operates in the pharmaceutical industry through its subsidiary, Fosun Pharma. The company is involved in the production and supply of pharmaceutical products, raw materials, and reagents, focusing on collaborations and agreements to enhance its market presence.
Average Trading Volume: 6,673,958
Technical Sentiment Signal: Sell
Current Market Cap: HK$40.24B
Learn more about 0656 stock on TipRanks’ Stock Analysis page.